Invizyne Technologies Inc.

• Invizyne Technologies Inc.
• Health Care

IZTC

Offering Team

Pre-IPO Investors

Deal Highlights

Invizyne is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought after chemicals. We believe that our biomanufacturing platform, known as SimplePath™, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology.

Our objective with SimplePath™ is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. We believe that SimplePath™ not only can maximize the value of these resources but also will contribute to the development of novel chemical compounds that should open new markets and business opportunities.

Our SimplePath™ platform consists of a series of modular cascading enzyme based biomanufacturing systems that leverage natural processes to perform complex chemical conversions, which systems may be coupled together or operate independently. Each system is comprised of several key parts (i.e. substrate(s), enzymes, cofactors, defined operating conditions, selected purification processes, and other system specific elements) that act together to produce one or more intended products.

Although established in 2019, our roots trace back to a decade-long research endeavor at Professor James Bowie’s laboratory at UCLA, where the core innovations underlying the SimplePath™ platform were developed. less

Invizyne is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought after chemicals. We believe that our biomanufacturing platform, known as SimplePath™, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. Our objective with SimplePath™ is to enabl More

Deal Tracker

Stock Price